
Am J Psychiatry 157:1108-1114, July 2000
© 2000 American Psychiatric Association
Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients
Amit Anand, , M.D.,
Paul Verhoeff, , M.D., Ph.D.,
Nicholas Seneca, , M.S.,
Sami S. Zoghbi, , Ph.D.,
John P. Seibyl, , M.D.,
Dennis S. Charney, , M.D., and
Robert B. Innis, , M.D., Ph.D.
OBJECTIVE: Increased dopaminergic neurotransmission has been implicated in the pathophysiology of bipolar disorder. However, it remains unclear whether the abnormality is due to increased dopamine release or enhanced postsynaptic receptor sensitivity. In this study, dopamine receptor imaging combined with a pharmacological challenge of amphetamine was used to assess both pre- and postsynaptic aspects of dopamine neurotransmission in euthymic bipolar disorder patients.METHOD: Thirteen patients with bipolar disorder (seven medication free and six receiving mood stabilizer therapy) who had been euthymic for more than 4 weeks and 13 age- and gender-matched healthy comparison subjects were included in the study. Single photon emission computed tomography scans were obtained with the striatal dopamine (D2/D3) receptor radiotracer iodobenzamide ([123I]IBZM) before and after an intravenous amphetamine challenge (0.3 mg/kg). Reduction in striatal [123I]IBZM binding potential from the first scan to the second scan was used as an indirect measure of the amount of dopamine released. Behavioral response to amphetamine was measured with the Brief Psychiatric Rating Scale, Young Mania Rating Scale, and visual analogue scales.RESULTS: Bipolar patients and healthy subjects did not differ in terms of mood state or striatal D2 receptor binding at baseline. Amphetamine challenge led to a significantly greater behavioral response in bipolar patients than in healthy subjects. However, there was no significant difference between the two groups in the amphetamine-induced decrease in striatal [123I]IBZM binding.CONCLUSIONS: In a group of euthymic patients with bipolar disorder, this study did not find evidence for increased striatal dopamine release. Instead, these data are consistent with enhanced postsynaptic dopamine responsivity in patients with bipolar disorder.
This article has been cited by other articles:

|
 |

|
 |
 
D. F. MACKINNON
Bipolar Disorder as Maladaptive Arousal: A Behavioral Model and Evidence
Ann. N.Y. Acad. Sci.,
May 1, 2008;
1129(1):
185 - 189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Stone, P. D. Morrison, and L. S. Pilowsky
Review: Glutamate and dopamine dysregulation in schizophrenia a synthesis and selective review
J Psychopharmacol,
June 1, 2007;
21(4):
440 - 452.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. DESARKAR, A. THAKUR, and V. K. SINHA
Aripiprazole-Induced Acute Dystonia
Am J Psychiatry,
June 1, 2006;
163(6):
1112 - 1113.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ferrie, A. H. Young, and R. McQuade
Effect of chronic lithium and withdrawal from chronic lithium on presynaptic dopamine function in the rat
J Psychopharmacol,
May 1, 2005;
19(3):
229 - 234.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. ANAND and A. SHEKHAR
Brain Imaging Studies in Mood and Anxiety Disorders: Special Emphasis on the Amygdala
Ann. N.Y. Acad. Sci.,
April 1, 2003;
985(1):
370 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kapur
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
Am J Psychiatry,
January 1, 2003;
160(1):
13 - 23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Smith, E. Kramer, C. R. Hermann, S. Goldberg, Y. Ma, V. Dhawan, A. Barnes, T. Chaly, A. Belakhleff, F. Laghrissi-Thode, et al.
Acute and Chronic Effects of Citalopram on Cerebral Glucose Metabolism in Geriatric Depression
Am J Geriatr Psychiatry,
December 1, 2002;
10(6):
715 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. N. Yatham, P. F. Liddle, R. W. Lam, I-S. Shiah, C. Lane, A. J. Stoessl, V. Sossi, and T. J. Ruth
PET Study of the Effects of Valproate on Dopamine D2 Receptors in Neuroleptic- and Mood-Stabilizer-Naive Patients With Nonpsychotic Mania
Am J Psychiatry,
October 1, 2002;
159(10):
1718 - 1723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. N. Yatham, P. F. Liddle, I-S. Shiah, R. W. Lam, E. Ngan, G. Scarrow, M. Imperial, J. Stoessl, V. Sossi, and T. J. Ruth
PET Study of [18F]6-Fluoro-L-Dopa Uptake in Neuroleptic- and Mood-Stabilizer-Naive First-Episode Nonpsychotic Mania: Effects of Treatment With Divalproex Sodium
Am J Psychiatry,
May 1, 2002;
159(5):
768 - 774.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2000
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|